WS #12202
Eli Lilly to acquire AtaiBeckley for up to $3.8B ($6.75/share cash upfront, ~40% premium to 30-day VWAP), with CVR tied to BPL-003 and VLS-01 milestones.
Eli Lilly Acquires AtaiBeckley for $3.8B
Eli Lilly to acquire AtaiBeckley for up to $3.8B ($6.75/share cash upfront, ~40% premium to 30-day VWAP), with CVR tied to BPL-003 and VLS-01 milestones.